|
XB--494199
Papers associated with grin1
???pagination.result.count???
???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 ???pagination.result.next???
Sort Newest To Oldest | Sort Oldest To Newest |
Modulation of NMDA receptor properties and synaptic transmission by the NR3A subunit in mouse hippocampal and cerebrocortical neurons., Tong G, Takahashi H, Tu S, Shin Y, Talantova M, Zago W, Xia P, Nie Z, Goetz T, Zhang D, Lipton SA, Nakanishi N., J Neurophysiol. January 1, 2008; 99 (1): 122-32. |
|
The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors., Madry C, Mesic I, Betz H, Laube B., Mol Pharmacol. December 1, 2007; 72 (6): 1535-44. |
|
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors., Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jørgensen L, Clausen RP, Wyllie DJ, Snyder JP, Traynelis SF., Mol Pharmacol. October 1, 2007; 72 (4): 907-20. |
|
Cleft-type cyclophanes confer neuroprotection against excitatory neurotoxicity in vitro and in vivo through inhibition of NMDA receptors., Masuko T, Nemoto Y, Nagaoka H, Miyake M, Kizawa Y, Kusama-Eguchi K, Kashiwagi K, Igarashi K, Kusama T., Neuropharmacology. September 1, 2007; 53 (4): 515-23. |
|
Anesthetic properties of the ketone bodies beta-hydroxybutyric acid and acetone., Yang L, Zhao J, Milutinovic PS, Brosnan RJ, Eger EI, Sonner JM., Anesth Analg. September 1, 2007; 105 (3): 673-9. |
|
Anesthetic-like modulation of a gamma-aminobutyric acid type A, strychnine-sensitive glycine, and N-methyl-d-aspartate receptors by coreleased neurotransmitters., Milutinovic PS, Yang L, Cantor RS, Eger EI, Sonner JM., Anesth Analg. August 1, 2007; 105 (2): 386-92. |
|
Ammonia has anesthetic properties., Brosnan RJ, Yang L, Milutinovic PS, Zhao J, Laster MJ, Eger EI, Sonner JM., Anesth Analg. June 1, 2007; 104 (6): 1430-3, table of contents. |
|
Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating., Sobolevsky AI, Prodromou ML, Yelshansky MV, Wollmuth LP., J Gen Physiol. June 1, 2007; 129 (6): 509-25. |
|
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block., Dravid SM, Erreger K, Yuan H, Nicholson K, Le P, Lyuboslavsky P, Almonte A, Murray E, Mosely C, Barber J, French A, Balster R, Murray TF, Traynelis SF., J Physiol. May 15, 2007; 581 (Pt 1): 107-28. |
|
Subunit counting in membrane-bound proteins., Ulbrich MH, Isacoff EY., Nat Methods. April 1, 2007; 4 (4): 319-21. |
|
Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function., Madry C, Mesic I, Bartholomäus I, Nicke A, Betz H, Laube B., Biochem Biophys Res Commun. March 2, 2007; 354 (1): 102-8. |
|
Molecular and functional studies of tilapia (Oreochromis mossambicus) NMDA receptor NR1 subunits., Tzeng DW, Lin MH, Chen BY, Chen YC, Chang YC, Chow WY., Comp Biochem Physiol B Biochem Mol Biol. March 1, 2007; 146 (3): 402-11. |
|
Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif., Takahashi H, Shin Y, Cho SJ, Zago WM, Nakamura T, Gu Z, Ma Y, Furukawa H, Liddington R, Zhang D, Tong G, Chen HS, Lipton SA., Neuron. January 4, 2007; 53 (1): 53-64. |
|
Activity-dependent neurotransmitter-receptor matching at the neuromuscular junction., Borodinsky LN, Spitzer NC., Proc Natl Acad Sci U S A. January 2, 2007; 104 (1): 335-40. |
|
Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor., Masuko T, Nagaoka H, Miyake M, Metori K, Kizawa Y, Kashiwagi K, Igarashi K, Kusama T., Neurochem Int. January 1, 2007; 50 (2): 443-9. |
|
PSD-95 and PKC converge in regulating NMDA receptor trafficking and gating., Lin Y, Jover-Mengual T, Wong J, Bennett MV, Zukin RS., Proc Natl Acad Sci U S A. December 26, 2006; 103 (52): 19902-7. |
|
NR3A modulates the outer vestibule of the "NMDA" receptor channel., Wada A, Takahashi H, Lipton SA, Chen HS., J Neurosci. December 20, 2006; 26 (51): 13156-66. |
|
Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission., Frizelle PA, Chen PE, Wyllie DJ., Mol Pharmacol. September 1, 2006; 70 (3): 1022-32. |
|
Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit., Wyllie DJ, Johnston AR, Lipscombe D, Chen PE., J Physiol. July 15, 2006; 574 (Pt 2): 477-89. |
|
Effects of anesthetics on mutant N-methyl-D-aspartate receptors expressed in Xenopus oocytes., Ogata J, Shiraishi M, Namba T, Smothers CT, Woodward JJ, Harris RA., J Pharmacol Exp Ther. July 1, 2006; 318 (1): 434-43. |
|
Differential modulation of human N-methyl-D-aspartate receptors by structurally diverse general anesthetics., Solt K, Eger EI, Raines DE., Anesth Analg. May 1, 2006; 102 (5): 1407-11. |
|
RNA interference of Xenopus NMDAR NR1 in vitro and in vivo., Miskevich F, Doench JG, Townsend MT, Sharp PA, Constantine-Paton M., J Neurosci Methods. April 15, 2006; 152 (1-2): 65-73. |
|
Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity., Woods AS, Kaminski R, Oz M, Wang Y, Hauser K, Goody R, Wang HY, Jackson SN, Zeitz P, Zeitz KP, Zolkowska D, Schepers R, Nold M, Danielson J, Gräslund A, Vukojevic V, Bakalkin G, Basbaum A, Shippenberg T., J Proteome Res. April 1, 2006; 5 (4): 1017-23. |
|
NMDA receptor subunit-dependent modulation by conantokin-G and Ala7-conantokin-G., Ragnarsson L, Yasuda T, Lewis RJ, Dodd PR, Adams DJ., J Neurochem. January 1, 2006; 96 (1): 283-91. |
|
Revisiting the postulated "unitary glutamate receptor": electrophysiological and pharmacological analysis in two heterologous expression systems fails to detect evidence for its existence., Schmidt C, Werner M, Hollmann M., Mol Pharmacol. January 1, 2006; 69 (1): 119-29. |
|
Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis., Hansen KB, Clausen RP, Bjerrum EJ, Bechmann C, Greenwood JR, Christensen C, Kristensen JL, Egebjerg J, Bräuner-Osborne H., Mol Pharmacol. December 1, 2005; 68 (6): 1510-23. |
|
Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids., Conti P, De Amici M, Grazioso G, Roda G, Pinto A, Hansen KB, Nielsen B, Madsen U, Bräuner-Osborne H, Egebjerg J, Vestri V, Pellegrini-Giampietro DE, Sibille P, Acher FC, De Micheli C., J Med Chem. October 6, 2005; 48 (20): 6315-25. |
|
Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels., Chen HS, Lipton SA., J Pharmacol Exp Ther. September 1, 2005; 314 (3): 961-71. |
|
Mechanism of partial agonist action at the NR1 subunit of NMDA receptors., Inanobe A, Furukawa H, Gouaux E., Neuron. July 7, 2005; 47 (1): 71-84. |
|
The NR3B subunit does not alter the anesthetic sensitivities of recombinant N-methyl-D-aspartate receptors., Yamakura T, Askalany AR, Petrenko AB, Kohno T, Baba H, Sakimura K., Anesth Analg. June 1, 2005; 100 (6): 1687-1692. |
|
Glutamate transporter type 3 attenuates the activation of N-methyl-D-aspartate receptors co-expressed in Xenopus oocytes., Zuo Z, Fang H., J Exp Biol. June 1, 2005; 208 (Pt 11): 2063-70. |
|
Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling., Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, Snyder JP, Traynelis SF, Wyllie DJ., Mol Pharmacol. May 1, 2005; 67 (5): 1470-84. |
|
Modulation of triheteromeric NMDA receptors by N-terminal domain ligands., Hatton CJ, Paoletti P., Neuron. April 21, 2005; 46 (2): 261-74. |
|
Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits., Chandra T, Maier W, König HG, Hirzel K, Kögel D, Schüler T, Chandra A, Demirhan I, Laube B., Neuroscience. January 1, 2005; 134 (1): 145-53. |
|
Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner., Masuko T, Suzuki I, Kizawa Y, Kusama-Eguchi K, Watanabe K, Kashiwagi K, Igarashi K, Kusama T., Neurosci Lett. November 16, 2004; 371 (1): 30-3. |
|
Ligand-binding residues integrate affinity and efficacy in the NMDA receptor., Kalbaugh TL, VanDongen HM, VanDongen AM., Mol Pharmacol. August 1, 2004; 66 (2): 209-19. |
|
Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors., Kashiwagi K, Tanaka I, Tamura M, Sugiyama H, Okawara T, Otsuka M, Sabado TN, Williams K, Igarashi K., J Pharmacol Exp Ther. June 1, 2004; 309 (3): 884-93. |
|
Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins., Iwamoto T, Yamada Y, Hori K, Watanabe Y, Sobue K, Inui M., J Neurochem. April 1, 2004; 89 (1): 100-8. |
|
Functional analysis of Caenorhabditis elegans glutamate receptor subunits by domain transplantation., Strutz-Seebohm N, Werner M, Madsen DM, Seebohm G, Zheng Y, Walker CS, Maricq AV, Hollmann M., J Biol Chem. November 7, 2003; 278 (45): 44691-701. |
|
Dynorphin A inhibits NMDA receptors through a pH-dependent mechanism., Kanemitsu Y, Hosoi M, Zhu PJ, Weight FF, Peoples RW, McLaughlin JS, Zhang L., Mol Cell Neurosci. November 1, 2003; 24 (3): 525-37. |
|
Structural model of the N-methyl-D-aspartate receptor glycine site probed by site-directed chemical coupling., Foucaud B, Laube B, Schemm R, Kreimeyer A, Goeldner M, Betz H., J Biol Chem. June 27, 2003; 278 (26): 24011-7. |
|
Molecular determinants of proton-sensitive N-methyl-D-aspartate receptor gating., Low CM, Lyuboslavsky P, French A, Le P, Wyatte K, Thiel WH, Marchan EM, Igarashi K, Kashiwagi K, Gernert K, Williams K, Traynelis SF, Zheng F., Mol Pharmacol. June 1, 2003; 63 (6): 1212-22. |
|
Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons., Williams K, Dattilo M, Sabado TN, Kashiwagi K, Igarashi K., J Pharmacol Exp Ther. May 1, 2003; 305 (2): 740-8. |
|
Staggering of subunits in NMDAR channels., Sobolevsky AI, Rooney L, Wollmuth LP., Biophys J. December 1, 2002; 83 (6): 3304-14. |
|
DRPEER: a motif in the extracellular vestibule conferring high Ca2+ flux rates in NMDA receptor channels., Watanabe J, Beck C, Kuner T, Premkumar LS, Wollmuth LP., J Neurosci. December 1, 2002; 22 (23): 10209-16. |
|
PSD-95 eliminates Src-induced potentiation of NR1/NR2A-subtype NMDA receptor channels and reduces high-affinity zinc inhibition., Yamada Y, Iwamoto T, Watanabe Y, Sobue K, Inui M., J Neurochem. May 1, 2002; 81 (4): 758-64. |
|
Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore., Kashiwagi K, Masuko T, Nguyen CD, Kuno T, Tanaka I, Igarashi K, Williams K., Mol Pharmacol. March 1, 2002; 61 (3): 533-45. |
|
Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids., Malayev A, Gibbs TT, Farb DH., Br J Pharmacol. February 1, 2002; 135 (4): 901-9. |
|
NMDA receptors formed by NR1 in Xenopus laevis oocytes do not contain the endogenous subunit XenU1., Green T, Rogers CA, Contractor A, Heinemann SF., Mol Pharmacol. February 1, 2002; 61 (2): 326-33. |
|
Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid, for rat N-methyl-D-aspartate receptor subunits., Sheinin A, Nahum-Levy R, Shavit S, Benveniste M., Neurosci Lett. January 11, 2002; 317 (2): 77-80. |
???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 ???pagination.result.next???